@misc{RomaoCoelhoSantosSilvaetal.2017,
  author    = {Romao, Maria Joao and Coelho, Catarina and Santos-Silva, Teresa and Foti, Alessandro and Terao, Mineko and Garattini, Enrico and Leimk{\"u}hler, Silke},
  title     = {Structural basis for the role of mammalian aldehyde oxidases in the metabolism of drugs and xenobiotics},
  series = {Current Opinion in Chemical Biology},
  volume    = {37},
  journal   = {Current Opinion in Chemical Biology},
  publisher = {Elsevier},
  address   = {Oxford},
  issn      = {1367-5931},
  doi       = {10.1016/j.cbpa.2017.01.005},
  pages     = {39 -- 47},
  year      = {2017},
  abstract  = {Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing aromatic/aliphatic aldehydes into the corresponding carboxylic acids and hydroxylating various heteroaromatic rings. Mammals are characterized by a complement of species specific AOX isoenzymes, that varies from one in humans (AOX1) to four in rodents (AOX1, AOX2, AOX3 and AOX4). The physiological function of mammalian AOX isoenzymes is unknown, although human AOX1 is an emerging enzyme in phase-I drug metabolism. Indeed, the number of therapeutic molecules under development which act as AOX substrates is increasing. The recent crystallization and structure determination of human AOX1 as well as mouse AOX3 has brought new insights into the mechanisms underlying substrate/inhibitor binding as well as the catalytic activity of this class of enzymes.},
  language  = {en}
}